NUVB · NYSE
Nuvation Bio (NUVB) Stock Price & Fundamentals
Nuvation Bio (NUVB) closed at $585.52 on Oct 9, 2026, down 1.46% from the previous close of $594.18.
Share price, past year
1Y +41.28%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $585.52 |
| Sep 30, 2026 | $606.74 |
| Aug 31, 2026 | $592.16 |
| Jul 31, 2026 | $555.61 |
| Jun 30, 2026 | $516.44 |
| May 29, 2026 | $507.59 |
| Apr 30, 2026 | $507.64 |
| Mar 31, 2026 | $495.33 |
| Feb 27, 2026 | $466.76 |
| Jan 30, 2026 | $445.50 |
| Dec 31, 2025 | $429.12 |
| Nov 28, 2025 | $413.68 |
| Oct 31, 2025 | $408.26 |
Key statistics
- Market cap
- $202.88B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.44
- Revenue (TTM)
- $169.90M
- Net income (TTM)
- −$149.83M
- Shares outstanding
- 346.5M
- Dividend yield
- —
- 52-week range
- $402.97 – $617.34
Nuvation Bio's market cap is $202.88B, based on a share price of $585.52 and 346.5M shares outstanding as of Jun 30, 2026.
Financials
Nuvation Bio reported revenue of $62.90M for fiscal 2025, up 698.96% from fiscal 2024.
Nuvation Bio reported a net loss of $204.63M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $62.90M | +699.0% | −$204.63M | −325.3% | −$0.60 | — |
| FY2024ended Dec 31, 2024 | $7.87M | — | −$567.94M | −7,213.8% | −$2.11 | — |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$75.80M | — | −$0.35 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $31.69M | −$62.84M | −$0.18 |
| Q1 FY2026ended Mar 31, 2026 | $83.23M | $5.40M | $0.01 |
| Q4 FY2025ended Dec 31, 2025 | $41.87M | −$36.59M | −$0.11 |
| Q3 FY2025ended Sep 30, 2025 | $13.12M | −$55.79M | −$0.16 |
| Q2 FY2025ended Jun 30, 2025 | $4.83M | −$59.01M | −$0.17 |
| Q1 FY2025ended Mar 31, 2025 | $3.08M | −$53.24M | −$0.16 |
| Q4 FY2024ended Dec 31, 2024 | $5.71M | −$49.45M | $0.00 |
| Q3 FY2024ended Sep 30, 2024 | $727.00K | −$41.21M | −$0.15 |
Company profile
- Name
- Nuvation Bio Inc.
- Ticker
- NUVB
- Exchange
- NYSE
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1500 Broadway, Suite 1401, New York, NY 10036
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001811063
Recent SEC filings
- Aug 6, 2026
- Aug 6, 2026
- Jul 6, 2026
- Jun 30, 2026
- May 27, 2026
- May 4, 2026
- May 4, 2026
- Mar 2, 2026
Frequently asked questions
What is Nuvation Bio's stock price?
Nuvation Bio (NUVB) closed at $585.52 on Oct 9, 2026, down 1.46% from the previous close of $594.18.
What is Nuvation Bio's market cap?
Nuvation Bio's market cap is $202.88B, based on a share price of $585.52 and 346.5M shares outstanding as of Jun 30, 2026.
How much revenue does Nuvation Bio make?
Nuvation Bio reported revenue of $62.90M for fiscal 2025, up 698.96% from fiscal 2024.
Does Nuvation Bio pay a dividend?
Nuvation Bio's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Nuvation Bio Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures